Screener
HealthEquity HQY Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: HealthEquity’s 10-Q, filed May 28, 2026.
- Filed
- May 28, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001428336-26-000028
| (in thousands, except per share data) | Three months ended April 30, 2026 | Three months ended April 30, 2025 |
|---|---|---|
| Service costs | 78,326 | 88,005 |
| Custodial costs | 11,655 | 10,747 |
| Interchange costs | 8,348 | 7,781 |
| Total cost of revenue | 98,329 | 106,533 |
| Gross profit | 256,312 | 224,311 |
| Operating expenses | ||
| Sales and marketing | 26,833 | 25,984 |
| Technology and development | 67,767 | 61,436 |
Item 1. Financial statements
FAQ
- What is HealthEquity's total cost of revenue?
- HealthEquity (HQY) reported total cost of revenue of $98.33M in Q1 2026.
- How has HealthEquity's total cost of revenue changed year-over-year?
- HealthEquity's total cost of revenue decreased by 7.7% year-over-year, from $106.53M to $98.33M.
- What is the long-term trend for HealthEquity's total cost of revenue?
- Over 4 years (2022 to 2026), HealthEquity's total cost of revenue has grown at a 4.8% compound annual growth rate (CAGR), from $331.79M to $400.31M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about HealthEquity's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude